| Entry |
|
| Name |
Prednisolone sodium phosphate (JP18/USP); Pediapred (TN) |
| Product |
ORAPRED (Concordia Pharmaceuticals), PEDIAPRED (Royal Pharmaceuticals), PREDNISOLONE SODIUM PHOSPHATE (Seton Pharmaceuticals) |
| Generic |
PREDNISOLONE SODIUM PHOSPHATE (A-S Medication Solutions), PREDNISOLONE SODIUM PHOSPHATE (A-S Medication Solutions), PREDNISOLONE SODIUM PHOSPHATE (ATLANTIC BIOLOGICALS CORP.), PREDNISOLONE SODIUM PHOSPHATE (Amneal Pharmaceuticals LLC), PREDNISOLONE SODIUM PHOSPHATE (Bausch & Lomb Incorporated), PREDNISOLONE SODIUM PHOSPHATE ORAL SOLUTION (BioComp Pharma), PREDNISOLONE SODIUM PHOSPHATE (Chartwell RX), PREDNISOLONE SODIUM PHOSPHATE (Edenbridge Pharmaceuticals LLC.), PREDNISOLONE SODIUM PHOSPHATE (Lohxa), PREDNISOLONE SODIUM PHOSPHATE (Morton Grove Pharmaceuticals), PREDNISOLONE SODIUM PHOSPHATE (PINNACLE PHARMA LLC), PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates), PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates), PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates), PREDNISOLONE SODIUM PHOSPHATE (Pharmaceutical Associates), PREDNISOLONE SODIUM PHOSPHATE (Prasco Laboratories), PREDNISOLONE SODIUM PHOSPHATE (Preferred Pharmaceuticals), PREDNISOLONE SODIUM PHOSPHATE (Proficient Rx LP), PREDNISOLONE SODIUM PHOSPHATE (RedPharm Drug) |
| Formula |
C21H27O8P. 2Na
|
| Exact mass |
484.1239
|
| Mol weight |
484.3876
|
| Structure |

|
| Simcomp |
|
| Class |
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
|
| Remark |
| Therapeutic category: | 2456 |
| ATC code: | A07EA01 C05AA04 D07AA03 D07XA02 H02AB06 R01AD02 S01BA04 S01CB02 S02BA03 S03BA02 |
| Chemical structure group: | DG00093 |
| Product (DG00093): | D00472<JP/US> D00980<JP/US> D00981<JP/US> D01239<JP> D03301<JP> |
| Product (mixture): | D11699<US> |
|
| Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
| Disease |
Atopic dermatitis [DS:H01358] Allergic rhinitis [DS:H01360] Bullous dermatitis herpetiformis [DS:H01362] Contact dermatitis [DS:H01357] Mycosis fungoides [DS:H01463] Pemphigus [DS:H01648] Severe erythema multiforme [DS:H01695] Stevens-Johnson syndrome [DS:H01694] Congenital adrenal hyperplasia [DS:H00216] Primary or secondary adrenocortical insufficiency [DS:H01598] Crohn's disease [DS:H00286] Ulcerative colitis [DS:H01466] Acquired (autoimmune) hemolytic anemia [DS:H01585] Diamond-Blackfan anemia [DS:H00237] Pure red cell aplasia [DS:H01586] Multiple sclerosis [DS:H01490] Acute or chronic solid organ rejection [DS:H00083] Chronic obstructive pulmonary disease [DS:H01714] Allergic bronchopulmonary aspergillosis [DS:H01328] Asthma [DS:H00079] Pulmonary tuberculosis [DS:H00342] Hypersensitivity pneumonitis [DS:H00346] Idiopathic bronchiolitis obliterans [DS:H01873] Idiopathic pulmonary fibrosis [DS:H01299] Pneumocystis carinii pneumonia [DS:H01521] Nephrotic syndrome [DS:H01657] Ankylosing spondylitis [DS:H01674] Dermatomyositis and polymyositis [DS:H01604] Polymyalgia rheumatica [DS:H01606] Temporal arteritis [DS:H01698] Psoriatic arthritis [DS:H01507] Relapsing polychondritis [DS:H01758] Rheumatoid arthritis [DS:H00630] Juvenile rheumatoid arthritis [DS:H01672] Sjogren's Syndrome [DS:H01502] Systemic lupus erythematosus [DS:H00080] Trichinosis with neurologic or myocardial involvement [DS:H01099] |
| Target |
NR3C1 (GR) [HSA:2908] [KO:K05771] |
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
| Interaction |
|
| Structure map |
| map07225 | Glucocorticoid and mineralocorticoid receptor agonists/antagonists |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07EA Corticosteroids acting locally
A07EA01 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
C CARDIOVASCULAR SYSTEM
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AA Corticosteroids
C05AA04 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AA Corticosteroids, weak (group I)
D07AA03 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07XA Corticosteroids, weak, other combinations
D07XA02 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AB Glucocorticoids
H02AB06 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD Corticosteroids
R01AD02 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA04 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01CB02 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
S02 OTOLOGICALS
S02B CORTICOSTEROIDS
S02BA Corticosteroids
S02BA03 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S03B CORTICOSTEROIDS
S03BA Corticosteroids
S03BA02 Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP)
Inflammatory Bowel Disease Agents
Glucocorticoids
Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP)
Ophthalmic Agents
Ophthalmic Anti-inflammatories
Glucocorticoids, Ophthalmic
Prednisolone
D00981 Prednisolone sodium phosphate (JP18/USP)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
245 Adrenal hormone preparations
2456 Prednisolones
D00981 Prednisolone sodium phosphate (JP18/USP)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00093 Prednisolone
D00981 Prednisolone sodium phosphate
Drug classes [BR:br08332]
Anti-inflammatory
DG01955 Corticosteroid
D00981 Prednisolone sodium phosphate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D00981 Prednisolone sodium phosphate (JP18/USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00981 Prednisolone sodium phosphate
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
DG00093 Prednisolone
|
| Other DBs |
|
| KCF data |
ATOM 32
1 C2x C 3.4829 -12.1384
2 C5x C 3.4829 -13.5014
3 C2x C 4.6633 -14.1829
4 C2y C 5.8437 -13.5014
5 C1z C 5.8437 -12.1384
6 C2x C 4.6633 -11.4568
7 C1x C 7.0241 -14.1829
8 C1x C 8.2045 -13.5014
9 C1y C 8.2045 -12.1384
10 C1y C 7.0241 -11.4568
11 C1y C 9.3850 -11.4568
12 C1z C 9.3850 -10.0938
13 C1x C 8.2045 -9.4123
14 C1y C 7.0241 -10.0938
15 C1x C 11.7457 -11.4568
16 C1x C 11.7457 -10.0938
17 C1z C 10.5654 -9.4123
18 O5x O 2.3025 -14.1829
19 C1a C 5.8437 -10.7753
20 O1a O 5.8457 -9.4135
21 C1a C 9.3850 -8.7308
22 C5a C 10.5654 -7.6348
23 O1a O 11.7457 -8.7308
24 C1b C 11.7497 -6.9511
25 O5a O 9.3889 -6.9555
26 O2b O 12.9156 -7.6243
27 P1b P 14.1511 -6.9106
28 O1c O 15.3635 -6.2106 #-
29 O1c O 13.4565 -5.7082 #-
30 O1c O 14.8569 -8.1325
31 Z Na 11.1300 -5.6700 #+
32 Z Na 17.5700 -6.0200 #+
BOND 33
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 2
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 2 18 2
22 5 19 1 #Up
23 14 20 1 #Up
24 12 21 1 #Up
25 17 22 1 #Up
26 17 23 1 #Down
27 22 24 1
28 22 25 2
29 24 26 1
30 26 27 1
31 27 28 1
32 27 29 1
33 27 30 2
|